Alan Whone

4.8k total citations · 1 hit paper
66 papers, 2.8k citations indexed

About

Alan Whone is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Alan Whone has authored 66 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Neurology, 18 papers in Cellular and Molecular Neuroscience and 11 papers in Cognitive Neuroscience. Recurrent topics in Alan Whone's work include Parkinson's Disease Mechanisms and Treatments (49 papers), Neurological disorders and treatments (32 papers) and Genetic Neurodegenerative Diseases (8 papers). Alan Whone is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (49 papers), Neurological disorders and treatments (32 papers) and Genetic Neurodegenerative Diseases (8 papers). Alan Whone collaborates with scholars based in United Kingdom, United States and Germany. Alan Whone's co-authors include David J. Brooks, Robert Y. Moore, Paola Piccini, Philippe Rémy, Claude Nahmias, Maeve A. Caldwell, Peter J. Cullen, Margaret R. Davis, Robert A. Hauser and Sven N. Reske and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alan Whone

64 papers receiving 2.8k citations

Hit Papers

Slower progression of Parkinson's disease with ropinirole... 2003 2026 2010 2018 2003 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
    2003 604 citations Alan Whone et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Whone United Kingdom 26 2.0k 1.0k 383 373 285 66 2.8k
Sharon Hassin‐Baer Israel 33 1.8k 0.9× 729 0.7× 540 1.4× 362 1.0× 388 1.4× 127 2.8k
Marina Svetel Serbia 28 1.8k 0.9× 933 0.9× 491 1.3× 239 0.6× 475 1.7× 149 2.9k
Beomseok Jeon South Korea 29 2.4k 1.2× 801 0.8× 402 1.0× 397 1.1× 424 1.5× 183 3.1k
Tommaso Schirinzi Italy 29 1.4k 0.7× 813 0.8× 708 1.8× 201 0.5× 328 1.2× 138 2.6k
Chun‐Hwei Tai Taiwan 26 1.2k 0.6× 854 0.8× 463 1.2× 214 0.6× 217 0.8× 80 2.2k
Ruwei Ou China 27 1.9k 0.9× 466 0.5× 503 1.3× 357 1.0× 399 1.4× 204 2.6k
Jarosław Sławek Poland 32 2.3k 1.1× 809 0.8× 379 1.0× 233 0.6× 286 1.0× 229 3.1k
Qianqian Wei China 28 2.0k 1.0× 521 0.5× 623 1.6× 253 0.7× 451 1.6× 210 2.8k
Ioannis U. Isaias Italy 38 3.1k 1.5× 1.5k 1.4× 203 0.5× 649 1.7× 406 1.4× 119 3.9k
Jan Linder Sweden 28 1.9k 1.0× 638 0.6× 473 1.2× 270 0.7× 354 1.2× 67 3.0k

Countries citing papers authored by Alan Whone

Since Specialization
Citations

This map shows the geographic impact of Alan Whone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Whone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Whone more than expected).

Fields of papers citing papers by Alan Whone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Whone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Whone. The network helps show where Alan Whone may publish in the future.

Co-authorship network of co-authors of Alan Whone

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Whone. A scholar is included among the top collaborators of Alan Whone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Whone. Alan Whone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morrison, Hamish, Nicholas Turner, Georgina Russell, et al.. (2024). Remote Evaluation of Sleep and Circadian Rhythms in Older Adults With Mild Cognitive Impairment and Dementia: Protocol for a Feasibility and Acceptability Mixed Methods Study. JMIR Research Protocols. 13. e52652–e52652. 1 indexed citations
2.
Barker, Roger A., Märt Saarma, Clive N. Svendsen, et al.. (2024). Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop. Journal of Parkinson s Disease. 14(8). 1659–1676. 3 indexed citations
3.
Morgan, Catherine, Alessandro Masullo, Majid Mirmehdi, et al.. (2023). Automated Real-World Video Analysis of Sit-to-Stand Transitions Predicts Parkinson’s Disease Severity. SHILAP Revista de lepidopterología. 7(1). 92–103. 7 indexed citations
4.
Jovan, Ferdian, Catherine Morgan, Ryan McConville, et al.. (2023). Multimodal Indoor Localisation in Parkinson's Disease for Detecting Medication Use: Observational Pilot Study in a Free-Living Setting. arXiv (Cornell University). 4273–4283. 2 indexed citations
5.
Morgan, Catherine, Emma L. Tonkin, Alessandro Masullo, et al.. (2023). A multimodal dataset of real world mobility activities in Parkinson’s disease. Scientific Data. 10(1). 918–918. 9 indexed citations
6.
Morrison, Hamish, Nicholas Turner, Amy Jolly, et al.. (2023). Remote evaluation of sleep to enhance understanding of early dementia due to Alzheimer’s Disease (RESTED-AD): an observational cohort study protocol. BMC Geriatrics. 23(1). 590–590. 5 indexed citations
7.
Boca, M, Michal Rolinski, Nadia L. Cerminara, et al.. (2023). Slower rates of prism adaptation but intact aftereffects in patients with early to mid-stage Parkinson's disease. Neuropsychologia. 189. 108681–108681.
8.
Morgan, Catherine, J. E. Jameson, Ian Craddock, et al.. (2022). Understanding how people with Parkinson's disease turn in gait from a real-world in-home dataset. Parkinsonism & Related Disorders. 105. 114–122. 5 indexed citations
9.
McConville, Ryan, Catherine Morgan, Róisín McNaney, et al.. (2021). Multimodal Classification of Parkinson’s Disease in Home Environments with Resiliency to Missing Modalities. Sensors. 21(12). 4133–4133. 17 indexed citations
10.
Peraza, Luis R., Kirsi M. Kinnunen, Róisín McNaney, et al.. (2021). An Automatic Gait Analysis Pipeline for Wearable Sensors: A Pilot Study in Parkinson’s Disease. Sensors. 21(24). 8286–8286. 13 indexed citations
11.
Baig, Fahd, M Boca, Lucy Mooney, et al.. (2021). Per-oral image guided gastrojejunostomy insertion for levodopa-carbidopa intestinal gel in Parkinson's disease is safe and may be advantageous. Parkinsonism & Related Disorders. 89. 34–37. 1 indexed citations
12.
13.
Carroll, Camille, Kara Stevens, Jane Vickery, et al.. (2019). Simvastatin as a neuroprotective treatment for Parkinson’s disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study. BMJ Open. 9(10). e029740–e029740. 25 indexed citations
14.
Selikhova, Marianna, Е А Катунина, & Alan Whone. (2019). PET and SPECT in the assessment of monoaminergic brain systems in extrapyramidal disorders. SHILAP Revista de lepidopterología. 13(2). 69–78. 2 indexed citations
15.
Tsivos, Demitra, et al.. (2017). . Explore Bristol Research. 37 indexed citations
16.
Henderson, Emily J., et al.. (2016). Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson’s Disease. Parkinson s Disease. 2016. 1–6. 7 indexed citations
17.
18.
Wang, Wenzhang, Xinglong Wang, Hisashi Fujioka, et al.. (2015). Parkinson's disease–associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes. Nature Medicine. 22(1). 54–63. 259 indexed citations
19.
Khan, Sadaquate, Shazia Javed, Lucy Mooney, et al.. (2012). Clinical outcomes from bilateral versus unilateral stimulation of the pedunculopontine nucleus with and without concomitant caudal zona incerta region stimulation in Parkinson's disease. British Journal of Neurosurgery. 26(5). 722–725. 26 indexed citations
20.
Plaha, Puneet, et al.. (2011). Bilateral caudal zona incerta nucleus stimulation for essential tremor: outcome and quality of life. Journal of Neurology Neurosurgery & Psychiatry. 82(8). 899–904. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon Hassin‐Baer Breakdown of academic impact, for papers by Marina Svetel Breakdown of academic impact, for papers by Beomseok Jeon Breakdown of academic impact, for papers by Tommaso Schirinzi Breakdown of academic impact, for papers by Chun‐Hwei Tai Breakdown of academic impact, for papers by Ruwei Ou Breakdown of academic impact, for papers by Jarosław Sławek Breakdown of academic impact, for papers by Qianqian Wei Breakdown of academic impact, for papers by Ioannis U. Isaias Breakdown of academic impact, for papers by Jan Linder
Rankless by CCL
2026